醫師代碼：25007

專 長 

• 骨髓幹細胞移植
• 細胞治療

現 職

• 花蓮慈濟醫院幹細胞與精準醫療研發中心 主任
• 花蓮慈濟醫院免疫暨微生物治療科 主任
• 花蓮慈濟醫院國際醫學中心主任
• 中華民國血液及骨髓移植學會 理事長

學 歷 

• 中國醫藥大學 中醫學系
• 成功大學醫學工程研究所 碩士

經 歷

• 花蓮慈濟醫院血液腫瘤科 主治醫師
• 台大癌症醫院籌備處 主治醫師
• 台大醫院血液科及腫瘤醫學部兼任主治醫師
• 台灣大學台成幹細胞治療中心 病房主任

專科證書

• 內科專科醫師證書
• 血液病專科醫師證書
• 腫瘤內科專科醫師證書
• 血液及骨髓移植專科醫師證書

專科學會

• 台灣內科學會
• 中華民國血液病學會
• 中華民國血液及骨髓移植學會
• 中華民國腫瘤內科學會

著作

1. Yu LC, Chang CH, Huang CP, Huang CY, Hong JH, Tai TY, Weng HY, Lo CW, Tsai CY, Lee YK, Tsai YC, Hsueh TY, Chen YT, Chen IH, Chiang BJ, Tseng JS, Wu CC, Lin WY, Chien TM, Sheu ZL, *Li CC, Ke HL, Li WM, Lee HY, Wu WJ, Yeh HC. Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in Taiwan.J Clin Med. 2020 Nov 27;9(12):3866. doi: 10.3390/jcm9123866.
    
2. Yang KL, *Li CC, Lin PY.A novel variant of HLA-C*12, HLA-C*12:130, detected in a Taiwanese individual.HLA. 2020 Nov 12. doi: 10.1111/tan.14132.
    
3. Yang KL, *Li CC, Lin PY.Discovery of the HLA-DRB1*14:227 allele, a variant of HLA-DRB1*14, in a Taiwanese bone marrow donor.HLA. 2020 Oct 26. doi: 10.1111/tan.14122.
    
4. Yang KL, *Li CC, Lin PY.Identification of an HLA-B*40:01:01:01 variant, HLA-B*40:33, in a Taiwanese individual.HLA. 2020 Oct 20. doi: 10.1111/tan.14117.
    
5. Yang KL, *Li CC, Lin PY.Detection of the HLA-A*33:146 allele in a Taiwanese individual.HLA. 2020 Oct 11. doi: 10.1111/tan.14104.
    
6. Yang KL, *Li CC, Lin PY.HLA-A*11:263 is found on the haplotype: HLA-A*11:263-C*03:04:01-B*13:01.HLA. 2020 Oct 10. doi: 10.1111/tan.14100.
    
7. Yang KL, *Li CC, Lin PY.Recognition of an HLA-C*03:04:01:01 variant, HLA-C*03:04:37, in a Taiwanese individual. HLA. 2021 Jan;97(1):78-80. doi: 10.1111/tan.14076. Epub 2020 Sep 27.
    
8. Yang KL, *Li CC, Lin PY.Recognition of the HLA-DRB1*07:13 allele in a Taiwanese bone marrow donor.HLA. 2020 Nov;96(5):655-656. doi: 10.1111/tan.14059. Epub 2020 Sep 4.
    
9. Yang KL, *Li CC, Lin PY.Identification of an HLA-B*35:01:01:01 variant, HLA-B*35:01:23, in a Taiwanese individual.HLA. 2020 Nov;96(5):635-637. doi: 10.1111/tan.14048. Epub 2020 Sep 1.
    
10. Yang KL, *Li CC, Lin PY.Detection of an HLA-C*01:02:01:01 variant, HLA-C*01:02:43, in a Taiwanese individual.HLA. 2020 Nov;96(5):645-646. doi: 10.1111/tan.14045. Epub 2020 Sep 1.
     
11. Yang KL, *Li CC, Lin PY.The novel HLA-DQB1*05:254 allele identified in a Taiwanese individual.HLA. 2020 Nov;96(5):659-660. doi: 10.1111/tan.14043. Epub 2020 Sep 1.
     
12. Yang KL,* Li CC, Lin PY.Detection of the HLA-A*02:935 allele in a Taiwanese individual.HLA. 2020 Nov;96(5):623-624. doi: 10.1111/tan.14021. Epub 2020 Aug 24.
     
13. Yang KL, *Li CC, Lin PY.Detection of the HLA-A*11:280 allele in a Taiwanese individual.HLA. 2020 Oct;96(4):493-495. doi: 10.1111/tan.13992. Epub 2020 Aug 3.
     
14. *Li CC, Lin CB, Chu SC, Huang WH, Lee JJ, Yang GG, Wang TF, Wu YF.Lymphocyte percentage and platelet count correlate with the treatment outcome to tyrosine kinase inhibitors in epidermal growth factor receptor-mutated lung adenocarcinoma.Medicine (Baltimore). 2020 Jul 17;99(29):e21275. doi: 10.1097/MD.0000000000021275.
     
15. Villanueva EQ 3rd, *Li CC, Lin PY, Yang KL.HLA-A, -B, and -DRB1 genotyping and haplotype frequencies among Filipinos living in the National Capital Region of the Philippines.Hum Immunol. 2020 Aug;81(8):397-398. doi: 10.1016/j.humimm.2020.06.003. Epub 2020 Jun 19.
     
16. Yang KL, *Li CC, Lin PY.Discovery of an HLA-A*33 variant, HLA-A*33:200, in a Taiwanese individual.HLA. 2020 Oct;96(4):507-508. doi: 10.1111/tan.13919. Epub 2020 Jun 11.
     
17. Ho TJ, Wu HC, Bharath Kumar V, Kuo WW, Weng YS, Yeh YL, Mahalakshmi B, Day CH,* Li CC, Huang CY.Danshen (Salvia miltiorhiza) inhibits Leu27 IGF-II-induced hypertrophy in H9c2 cells.Environ Toxicol. 2020 Oct;35(10):1043-1049. doi: 10.1002/tox.22940. Epub 2020 May 16.
     
18. Yang KL, *Li CC, Lin PY.Recognition of an HLA-A*24:02 variant, HLA-A*24:02:31, in a Taiwanese individual.HLA. 2020 Sep;96(3):331-332. doi: 10.1111/tan.13898. Epub 2020 May 5.
     
19. Yang KL, *Li CC, Lin PY.Recognition of HLA-B*15:56, a variant of HLA-B*15, in a Taiwanese individual.HLA. 2020 Aug;96(2):215-216. doi: 10.1111/tan.13867. Epub 2020 Mar 22.
     
20. Yang KL, *Li CC, Lin PY.HLA-DQB1*05:05:02, an HLA-DQB1*05:05 variant, identified in a Taiwanese individual.HLA. 2020 Jul;96(1):124-125. doi: 10.1111/tan.13847. Epub 2020 Feb 24.
     
21. Yang KL, *Li CC, Lin PY.Detection of an HLA-A*02 variant, HLA-A*02:346, in a Taiwanese individual.HLA. 2020 Aug;96(2):203-204. doi: 10.1111/tan.13835. Epub 2020 Feb 18.
     
22. Wu YF, Huang WH, Gu MH, Lin SR, Chu SC, Wang TF, *Li CC.Higher CD56+ or CD2+ lymphocyte percentage predicts poor steroid response in patients with immune thrombocytopenia.Thromb Res. 2019 Nov;183:63-68. doi: 10.1016/j.thromres.2019.10.011. Epub 2019 Oct 20.
     
23. Liu JH, Liao XW, Chen CH, Yao M, *Li CC, Lin CT, Tsai CH, Chou WC, Hou HA, Huang SY, Wu SJ, Chen YC, Tien HF, Tang JL, Ko BS.Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study.Br J Haematol. 2019 Jul;186(1):72-85. doi: 10.1111/bjh.15884. Epub 2019 Mar 28.
     
24. *Lee CC, Chang HH, Lu MY, Yang YL, Chou SW, Lin DT, Jou ST, Yao M, Li CC, Yeh SP, Chen MH, Gau JP, Li SS, Wang PN, Liu YC, Wang TF, Tan TD, Lee MY, Yu MS, Wang CC, Lin SC, Chen YC, Su YC, Su KY, Lin KH.The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan.Ann Hematol. 2019 Mar;98(3):745-752. doi: 10.1007/s00277-019-03604-2. Epub 2019 Jan 21.